Nonalcoholic steatohepatitis heralding olmesartan-induced sprue-like enteropathy

Nonalcoholic fatty liver disease (NAFLD) may occur secondarily to several medical conditions. Celiac sprue is the prototypic intestinal condition leading to diverse liver changes, including steatosis/steatohepatitis via increased intestinal permeability [1,2]. Olmersartan has consistently been associated with sprue-like enteropathy [3,4]. Hence, it is tempting to speculate that, similar to what occurs in celiac sprue, liver injury could be a common finding also in olmesartan-induced enteropathy.

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2ahZkRV
via IFTTT